Onconova Therapeutics ASH Poster To Focus on Narazaciclib in MCL streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Preclinical data indicate that narazaciclib shows monotherapy and combination anti-tumor activity in ibrutinib-sensitive and resistant cells and xenograft models NEWTOWN, Pa., Nov. 02, 2023 .
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note issued to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $11.00 target price on shares of Onconova Therapeutics in a research note on […]
Dr. Victor Moyo has been appointed as the Chief Medical Officer at Onconova Therapeutics, Inc, a US-based clinical-stage Biopharmaceutical Company. Dr. Moyo bri.
Dr. Victor Moyo has been appointed as the Chief Medical Officer at Onconova Therapeutics, Inc, a US-based clinical-stage Biopharmaceutical Company. Dr. Moyo brings with him extensive experience as a physician, researcher, and drug developer in the pharmaceutical industry. He has held various senior leadership positions, overseeing clinical development plans, IND filings, NDA filings, and post-market…